EP2391633A1 - Process for the recovery of beta-acetylfuranoside - Google Patents

Process for the recovery of beta-acetylfuranoside

Info

Publication number
EP2391633A1
EP2391633A1 EP10700424A EP10700424A EP2391633A1 EP 2391633 A1 EP2391633 A1 EP 2391633A1 EP 10700424 A EP10700424 A EP 10700424A EP 10700424 A EP10700424 A EP 10700424A EP 2391633 A1 EP2391633 A1 EP 2391633A1
Authority
EP
European Patent Office
Prior art keywords
acf
acetylation
distillation
acetylfuranoside
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10700424A
Other languages
German (de)
French (fr)
Other versions
EP2391633B1 (en
Inventor
Martin Behringer
Bernd Junghans
Bernhard Knipp
Bernhard Pfeil
Gerald Zieres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to EP10700424.4A priority Critical patent/EP2391633B1/en
Priority to PL10700424T priority patent/PL2391633T3/en
Priority to SI201030937T priority patent/SI2391633T1/en
Publication of EP2391633A1 publication Critical patent/EP2391633A1/en
Application granted granted Critical
Publication of EP2391633B1 publication Critical patent/EP2391633B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Definitions

  • the present invention is directed to a novel process for the recovery of further ⁇ - Acetylfuranoside ( ⁇ -ACF, ⁇ -5-deoxy-l,2,3-tri-O-acetyl-D-ribofuranose) from mother liquors and process waste streams remaining from an initial synthesis of ACF.
  • ⁇ -ACF ⁇ - Acetylfuranoside
  • ACF can be prepared according to well known methods, as for example described in Helvetica Chimica Acta, Vol. 65 (Nr.149), Fasc. 5, 1982, 1531.
  • the synthesis of ACF leads to a racemic mixture of ⁇ - and ⁇ -ACF which can be separated by selective crystallization and thus precipitation from the reaction mixture.
  • the ⁇ -ACF is the desired product, as it is a valuable starting material used in the manufacture of inter alia cytidine derivatives, such as capecitabine.
  • Capecitabine is the active ingredient of the medicament XelodaTM.
  • the ACF synthesis can be summarized according to the following reaction scheme 1 :
  • the remaining, residual reaction mixture (mother liquor) contains about 8-15 weight-% of not precipitated ⁇ / ⁇ -Acetylfuranoside (ratio ⁇ : ⁇ is about
  • the advantages of the method according to the present invention are the increase of the overall yield of ⁇ -ACF, and consequently also of capecitabine per production cycle, thereby reducing the overall production costs.
  • the present method renders the entire manufacturing more environmentally friendly due to avoiding of unnecessary high amounts of chemical waste.
  • the method according to the present invention can also optionally be repeated in several serially connected cycles, thereby further improving the efficacy of the present method.
  • the present invention provides a method for recovery of initially not separated ⁇ -ACF from mother liquor remaining from the synthesis of ACF, wherein the ⁇ -ACF is recovered by a combination of at least one distillation method and at least one chemical reaction step.
  • step a) and b) Optional repetition of step a) and b) in a sequential (clockwise) cyclic process.
  • the distillation to about 60 to 80 weight-% in process step a) as described above is carried out at 1 to 3 mbar and 200 to 210 0 C heating temperature in a continuous thin- film evaporator.
  • the mixture which has to be distilled does surprisingly not decompose under these conditions though normally ⁇ - Acetylfuranoside begins to decompose at 150 0 C.
  • step b) comprises the de-acetylation of ⁇ / ⁇ -ACF in the presence of a suitable base, followed by neutralization with a suitable acid and further followed by the re-acetylation reaction in the presence of suitable base, a suitable catalyst and a suitable acetylating agent.
  • the process step a) as described above is carried out according to the specific conditions as described in the accompanying Example 1; and the process step b) is carried out according to the specific conditions as described in the accompanying Example 2.
  • mother liquor means any remaining mixture of residual starting materials or by-products left over after a main reaction product is isolated from that mixture in any step according to the present method.
  • mother liquor means the remaining mixture subsequent to the synthesis of ACF according to scheme 1 above, which contains residual amounts of ⁇ / ⁇ -ACF together with a variety of impurities and by-products.
  • distillation or “distillation method” as used herein preferably means falling- film evaporator, molecular distillation, centrifugal molecular distillation, continuous simple distillation or related apparatus.
  • a particularly preferred distillation method according to the present invention is the use of a thin-film evaporator.
  • suitable solvent in connection with the crystallization of ⁇ - ACF preferably means aliphatic alcohols, most preferably propan-2-ol.
  • chemical reaction step or “chemical conversion” as used herein means the conversion of the mixture of ⁇ - and ⁇ -Acetylfuranoside ( ⁇ / ⁇ -ACF), which are both present in a ratio ⁇ :B of about 1 :1, towards an increased amount of ⁇ -Acetylfuranoside by a series of chemical reaction steps, in particular by de-acetylation and subsequent re-acetylation.
  • suitable base in connection with the de-acetylation in step b) as described herein means alkali hydroxides or alkali alcoholates, preferably sodium methanolate (sodium methoxide).
  • suitable acid in connection with step b) as described herein means any conventional acid, preferably hydrochloric acid.
  • suitable base in connection with the re-acetylation in step b) as described herein means a base, preferably aliphatic or aromatic amines, most preferably triethylamine, n- methylpiperidine or pyridine.
  • suitable acetylation agent in connection with re-acetylation in step b) as described herein means acetic anhydride or acetyl halides, e. g. acetyl chloride.
  • suitable catalyst in connection with the re-acetylation in step b) as described herein means substituted amino-pyridines, preferably 4-dimethylaminopyridine.
  • the de-acetylation mentioned under step b) above is preferably carried out in aliphatic alcohols, in particular methanol, as solvents and at temperatures between 0 and -20 0 C, preferably -5 and -10 0 C. Subsequently, the reaction mixture is neutralized with a mineral acid, preferably hydrochloric acid, up to pH 4-6, preferably 5.
  • a mineral acid preferably hydrochloric acid, up to pH 4-6, preferably 5.
  • the initial solvent thus the aliphatic alcohol, is removed by distillation and replaced by a new solvent selected from chlorinated hydrocarbons, preferably methylenchloride or aromatic hydrocarbons, preferably toluene.
  • re-acetylation is carried out by the addition of a suitable amine, preferably triethylamine, 4-dimethylaminopyridine and acetic anhydride at temperatures of below 30 0 C, preferably 15°C to 20 0 C.
  • a suitable amine preferably triethylamine, 4-dimethylaminopyridine and acetic anhydride
  • steps a) and b) are given below and in particular by the accompanying working examples.
  • step c) The optional repetition of the sequential recovery cycle according to the present invention as mentioned under step c) above, can be carried out as many times as necessary. Possible limitations in the number of recovery cycles may arise from technical and chemical considerations, for example if no further ⁇ -ACF can be recovered or if the amount of recovered ⁇ -ACF becomes to small to justify the costs of the further continuation of the recovery cycle.
  • the mother liquor/waste stream solvent is removed ("Desolventizing") under reduced pressure (0 to 1000 mbar, preferably 0 to 200 mbar) and at 10 to 100 0 C, preferably 30 to 80 0 C
  • the obtained evaporation residue is feeded to a continuous or semi-continuous distillation as thin- film evaporator, falling-film evaporator, molecular distillation, centrifugal molecular distillation, continuous simple distillation or related apparatus.
  • the use of a thin- film evaporator or molecular distillation is especially preferred.
  • the residue is than distilled under reduced pressure at 0 to 10 mbar, preferably 0 to 5 mbar, and 100-210 0 C heating temperature (preferably 180-210 0 C).
  • the distillate can be used and processed as crude oil or is dissolved and crystallized from organic solvent (preferably propan-2- ol).
  • solvent from the initial ACF synthesis (scheme 1) is distilled off.
  • a suitable solvent such as aliphatic alcohols, preferably methanol and a suitable base such as alkali hydroxides or alkali alcoholates, preferably sodium methoxide, at reaction temperatures of O 0 C to -20 0 C, preferably at -5°C to - 10 0 C.
  • the reaction mixture is neutralized with an acid, preferably hydrochloric acid, up to pH 4-6, preferably 5.
  • the alcohol is distilled off and the residue treated with a suitable solvent such as chlorinated hydrocarbons, preferably methylenchloride or aromatic hydrocarbons, preferably toluene.
  • acetic anhydride is added slowly at batch temperatures of below 30 0 C, preferably 15°C to 20 0 C 4-dimethylaminopyridine and additionally acetic anhydride are added.
  • the batch is quenched with water and a suitable solvent such as chlorinated hydrocarbons, preferably methylenchloride or aromatic hydrocarbons, preferably toluene is added.
  • the organic layer is separated and the aqueous layer several times extracted with the suitable solvent mentioned above.
  • the combined organic layers are washed with an alkali solution, preferably sodium bicarbonate, leading to pH 8 after washing and further washed with water.
  • the solvent is distilled off and ⁇ -ACF crystallized in suitable solvents such as aliphatic alcohols, preferably propan-2-ol.
  • suitable solvents such as aliphatic alcohols, preferably propan-2-ol.
  • the crude product is recrystallized in a suitable solvent such as aliphatic alcohols, preferably propan-2-ol, resulting in white ⁇ -Acetylfurano side crystals with a content of ⁇ 2 weight-% of the ⁇ -anomer.
  • the method described herein is also referred to as "Chemical Reprocessing" in figure 1 which further summarizes the present process. Brief Description of the Drawings
  • Fig. 1 Process flow chart summarizing the process according to the present invention
  • Acetylfuranoside mother liquor (ratio ⁇ / ⁇ 35:65) was evaporated to an oil (residual solvent ⁇ 1 %) at 30 to 80 0 C and 5 to 100 mbar (about 1000 kg residual oil).
  • the residual oil was distilled under vacuum at 1 to 3 mbar and 200 to 210 0 C steam heating temperature in a continuous thin- film evaporator resulting in 609 kg distillate (containing ⁇ / ⁇ - Acetylfuranoside) and about 400 kg residue.
  • Acetylfuranoside mother liquor (about 250 kg ⁇ / ⁇ -Acetylfuranoside) was concentrated by distillation to obtain an oily residue (ratio ⁇ / ⁇ 60:40). Then 1060 L of methanol was added and cooled to -8 0 C. 127 L of sodium methoxide was then added and stirred for 3 hours. The reaction mixture was neutralized with 126 L of semi concentrated hydrochloric acid to bring the pH to 5.1.

Abstract

It is the objective of the present invention to provide an improved method for the recovery of residual, unseparated β-ACF from reaction mixtures remaining from an initial synthesis of ACF, which is in particular usable on a large industrial scale, more particularly in the production of capecitabine.

Description

PROCESS FOR THE RECOVERY OF BETA-ACETYLFURANOSIDE
The present invention is directed to a novel process for the recovery of further β- Acetylfuranoside (β-ACF, β-5-deoxy-l,2,3-tri-O-acetyl-D-ribofuranose) from mother liquors and process waste streams remaining from an initial synthesis of ACF.
ACF can be prepared according to well known methods, as for example described in Helvetica Chimica Acta, Vol. 65 (Nr.149), Fasc. 5, 1982, 1531. The synthesis of ACF leads to a racemic mixture of α- and β-ACF which can be separated by selective crystallization and thus precipitation from the reaction mixture. Usually the β-ACF is the desired product, as it is a valuable starting material used in the manufacture of inter alia cytidine derivatives, such as capecitabine. Capecitabine is the active ingredient of the medicament Xeloda™. The ACF synthesis can be summarized according to the following reaction scheme 1 :
β-Acetylfuranoside α/β-Acetylfuranoside
Scheme 1 EP 0 021 231 as well as WO 2005/040184 disclose the further reaction of the unseparated ACF racemic mixture, containing both α- and β-ACF, to a final product. The separation is thus only carried out subsequent to the reaction of the β-anomer to the desired end product.
In any of the known methods the remaining, residual reaction mixture (mother liquor) contains about 8-15 weight-% of not precipitated α/β-Acetylfuranoside (ratio α : β is about
35 : 65), which is not separated from the reaction mixture. Consequently, and in particular when used on an industrial scale, considerable amounts of valuable β-ACF are wasted, huge amounts of waste residue have to be worked-up and the costs for the entire manufacturing process up to the final product rise significantly.
It is therefore the objective of the present invention to provide an improved method for the recovery of residual, unseparated β-ACF from reaction mixtures remaining from an initial synthesis of ACF, which is in particular usable on a large industrial scale, more particularly in the production of 5"-deoxy-5-fluoro-N-(pentyloxycarbonyl) cytidine (capecitabine). The advantages of the method according to the present invention are the increase of the overall yield of β-ACF, and consequently also of capecitabine per production cycle, thereby reducing the overall production costs. In addition, the present method renders the entire manufacturing more environmentally friendly due to avoiding of unnecessary high amounts of chemical waste. The method according to the present invention can also optionally be repeated in several serially connected cycles, thereby further improving the efficacy of the present method.
Summary of the invention
In one embodiment, the present invention provides a method for recovery of initially not separated β-ACF from mother liquor remaining from the synthesis of ACF, wherein the β-ACF is recovered by a combination of at least one distillation method and at least one chemical reaction step.
In a preferred embodiment the method according to the present invention comprises the following sequential reaction steps:
a) Evaporation to less than 1 % residual solvent of the mother liquor remaining from an initial synthesis of ACF, to increase the content of residual α/β-ACF from about 8 to 15 weight-% to about 25 to 45 weight-%, followed by distillation to about
60 to 80 weight-% and subsequent crystallization of β-ACF out of the distillate by adding a suitable solvent; b) Chemical conversion of α/β-ACF mixture remaining in the mother liquor of step a), to β-ACF by de-acetylation and subsequent re-acetylation, followed by crystallization of β-ACF by addition of a suitable solvent;
c) Optional repetition of step a) and b) in a sequential (clockwise) cyclic process.
In still another preferred embodiment according to the present invention, the distillation to about 60 to 80 weight-% in process step a) as described above is carried out at 1 to 3 mbar and 200 to 210 0C heating temperature in a continuous thin- film evaporator. The mixture which has to be distilled does surprisingly not decompose under these conditions though normally β- Acetylfuranoside begins to decompose at 1500C.
In yet another preferred embodiment there is provided the method as described above, wherein step b) comprises the de-acetylation of α/β-ACF in the presence of a suitable base, followed by neutralization with a suitable acid and further followed by the re-acetylation reaction in the presence of suitable base, a suitable catalyst and a suitable acetylating agent.
In a particularly preferred embodiment according to the present invention, the process step a) as described above is carried out according to the specific conditions as described in the accompanying Example 1; and the process step b) is carried out according to the specific conditions as described in the accompanying Example 2.
In another particularly preferred embodiment there is provided the process for recovery of β-ACF according to the present invention used during the manufacture of capecitabine.
Detailed Description of the Invention
Definitions
The term "mother liquor" means any remaining mixture of residual starting materials or by-products left over after a main reaction product is isolated from that mixture in any step according to the present method. In particular, as used herein the term mother liquor means the remaining mixture subsequent to the synthesis of ACF according to scheme 1 above, which contains residual amounts of α/β-ACF together with a variety of impurities and by-products.
The term "distillation" or "distillation method" as used herein preferably means falling- film evaporator, molecular distillation, centrifugal molecular distillation, continuous simple distillation or related apparatus. A particularly preferred distillation method according to the present invention is the use of a thin-film evaporator.
The term "suitable solvent" in connection with the crystallization of β- ACF preferably means aliphatic alcohols, most preferably propan-2-ol.
The term "chemical reaction step" or "chemical conversion" as used herein means the conversion of the mixture of α- and β-Acetylfuranoside (α/β-ACF), which are both present in a ratio α:B of about 1 :1, towards an increased amount of β-Acetylfuranoside by a series of chemical reaction steps, in particular by de-acetylation and subsequent re-acetylation.
The term "suitable base" in connection with the de-acetylation in step b) as described herein means alkali hydroxides or alkali alcoholates, preferably sodium methanolate (sodium methoxide).
The term "suitable acid" in connection with step b) as described herein means any conventional acid, preferably hydrochloric acid.
The term "suitable base" in connection with the re-acetylation in step b) as described herein means a base, preferably aliphatic or aromatic amines, most preferably triethylamine, n- methylpiperidine or pyridine.
The term "suitable acetylation agent" in connection with re-acetylation in step b) as described herein means acetic anhydride or acetyl halides, e. g. acetyl chloride.
The term "suitable catalyst" in connection with the re-acetylation in step b) as described herein means substituted amino-pyridines, preferably 4-dimethylaminopyridine.
The de-acetylation mentioned under step b) above is preferably carried out in aliphatic alcohols, in particular methanol, as solvents and at temperatures between 0 and -20 0C, preferably -5 and -10 0C. Subsequently, the reaction mixture is neutralized with a mineral acid, preferably hydrochloric acid, up to pH 4-6, preferably 5. The initial solvent, thus the aliphatic alcohol, is removed by distillation and replaced by a new solvent selected from chlorinated hydrocarbons, preferably methylenchloride or aromatic hydrocarbons, preferably toluene. Subsequently re-acetylation is carried out by the addition of a suitable amine, preferably triethylamine, 4-dimethylaminopyridine and acetic anhydride at temperatures of below 300C, preferably 15°C to 200C.
Further details of the conditions for both steps a) and b) as described herein, together with appropriate work-up procedures, are given below and in particular by the accompanying working examples. The sequential use of steps a) and b), optionally followed by c), according to the specifϊc parameters, temperature ranges, substances, solvents and conditions used in the disclosed working examples 1 and 2, respectively form a further particularly preferred embodiment according to the present invention.
The optional repetition of the sequential recovery cycle according to the present invention as mentioned under step c) above, can be carried out as many times as necessary. Possible limitations in the number of recovery cycles may arise from technical and chemical considerations, for example if no further β-ACF can be recovered or if the amount of recovered β-ACF becomes to small to justify the costs of the further continuation of the recovery cycle.
The essential process steps according to the present invention can be generally carried out as follows:
Distillative Recovery of β-Acetylfuranoside
Mother liquors and waste streams remaining from the chemical standard procedure to obtain β-ACF according to scheme 1 above, contain considerable amounts of α/β- Acetylfuranoside besides a variety of impurities and by-products.
After the mother liquor/waste stream solvent is removed ("Desolventizing") under reduced pressure (0 to 1000 mbar, preferably 0 to 200 mbar) and at 10 to 1000C, preferably 30 to 800C, the obtained evaporation residue is feeded to a continuous or semi-continuous distillation as thin- film evaporator, falling-film evaporator, molecular distillation, centrifugal molecular distillation, continuous simple distillation or related apparatus. The use of a thin- film evaporator or molecular distillation is especially preferred.
The residue is than distilled under reduced pressure at 0 to 10 mbar, preferably 0 to 5 mbar, and 100-2100C heating temperature (preferably 180-210 0C). The distillate can be used and processed as crude oil or is dissolved and crystallized from organic solvent (preferably propan-2- ol).
Chemical conversion of ACF mother liquor
The conversion of α/β-Acetylfuranoside to β-Acetylfuranoside can be carried out according to the process of scheme 2 below: OAc
Acetylfurano side Triol MW = 260,249 MW = 134,35 Acetylfuranoside MW = 260,249
Scheme 2
In a first step, solvent from the initial ACF synthesis (scheme 1) is distilled off. The following deacetylation is carried out with a suitable solvent such as aliphatic alcohols, preferably methanol and a suitable base such as alkali hydroxides or alkali alcoholates, preferably sodium methoxide, at reaction temperatures of O0C to -200C, preferably at -5°C to - 100C.
The reaction mixture is neutralized with an acid, preferably hydrochloric acid, up to pH 4-6, preferably 5. The alcohol is distilled off and the residue treated with a suitable solvent such as chlorinated hydrocarbons, preferably methylenchloride or aromatic hydrocarbons, preferably toluene.
After addition of an amine, preferably triethylamine, acetic anhydride is added slowly at batch temperatures of below 300C, preferably 15°C to 200C 4-dimethylaminopyridine and additionally acetic anhydride are added. The batch is quenched with water and a suitable solvent such as chlorinated hydrocarbons, preferably methylenchloride or aromatic hydrocarbons, preferably toluene is added.
The organic layer is separated and the aqueous layer several times extracted with the suitable solvent mentioned above. The combined organic layers are washed with an alkali solution, preferably sodium bicarbonate, leading to pH 8 after washing and further washed with water. The solvent is distilled off and β-ACF crystallized in suitable solvents such as aliphatic alcohols, preferably propan-2-ol. The crude product is recrystallized in a suitable solvent such as aliphatic alcohols, preferably propan-2-ol, resulting in white β -Acetylfurano side crystals with a content of < 2 weight-% of the α-anomer. The method described herein is also referred to as "Chemical Reprocessing" in figure 1 which further summarizes the present process. Brief Description of the Drawings
Fig. 1 : Process flow chart summarizing the process according to the present invention
Examples
The invention is now further illustrated by the followings working examples, which are by no means intended to limit the scope of the present method.
Example 1: Distillative Recovery of β-Acetylfuranoside
Distillation
3000 kg Acetylfuranoside mother liquor (ratio α/β 35:65) was evaporated to an oil (residual solvent < 1 %) at 30 to 800C and 5 to 100 mbar (about 1000 kg residual oil). The residual oil was distilled under vacuum at 1 to 3 mbar and 200 to 2100C steam heating temperature in a continuous thin- film evaporator resulting in 609 kg distillate (containing α/β- Acetylfuranoside) and about 400 kg residue.
Crystallization
1247 kg distillate (ratio α/β 35:65) was dissolved in 541 L propan-2-ol at 20 to 25°C and cooled to -12 to -8°C. The resulting suspension was agitated for 6 hours to complete crystallization. The crystallizate was isolated and washed with cold propan-2-ol.
425 kg of white crude product was obtained (2-3% residual moisture).
755 kg of crude product was recrystallized from propan-2-ol (ratio 1 : 1) under the same conditions. Yield: 748 kg β- Acetylfuranoside.
Example 2: Chemical Conversion of a/β-Acetylfuranoside
811 kg Acetylfuranoside mother liquor (about 250 kg α/β-Acetylfuranoside) was concentrated by distillation to obtain an oily residue (ratio α/β 60:40). Then 1060 L of methanol was added and cooled to -80C. 127 L of sodium methoxide was then added and stirred for 3 hours. The reaction mixture was neutralized with 126 L of semi concentrated hydrochloric acid to bring the pH to 5.1.
1235 L of solvents were distilled off. 212 L of toluene; 322 L of triethylamine and 42 L of toluene were added. 265 L of acetic anhydride were added slowly, keeping the batch temperature between 15-17°C. The mixture was stirred at 16-17°C for 1.5 hours. 6.06 kg of 4- dimethylaminopyridine and additionally 367 L of acetic anhydride were added. The batch was stirred for 1.5 hours. The reaction mixture was quenched with 212 L of water and 265 L of toluene were added. After the aqueous layer was separated, it was extracted 3 times with 265 L of toluene. The combined organic layers were washed twice with 550 L of saturated sodium bicarbonate solution, leading to pH 8 after washing, and 530 L of water. Toluene was then distilled off and 424 L of propan-2-ol were added and the residue dissolved. The solution was cooled to -9°C for 6 hours. The crystallizate was isolated and washed with cold propan-2-ol. 205.2 kg of white product were obtained (2-3 % residual moisture). Finally, the crude product was recrystallized with 205 L of propan-2-ol. Yield: 187.8 kg β-Acetylfuranoside.

Claims

Claims
1. A method for recovery of initially not separated β-ACF from mother liquor remaining from the synthesis of ACF, wherein the β-ACF is recovered by a combination of at least one distillation method and at least one chemical reaction step.
2. The method according to claim 1 comprising the following sequential steps:
a) Evaporation to less than 1 % residual solvent of the mother liquor remaining from an initial synthesis of ACF, to increase the content of residual α/β-ACF from about 8 to 15 weight-% to about 25 to 45 weight-%, followed by distillation to about 60 to 80 weight-% and subsequent crystallization of β-ACF out of the distillate by adding a suitable solvent;
b) Chemical conversion of α/β-ACF mixture remaining in the mother liquor of step a), to β-ACF by de-acetylation and subsequent re-acetylation, followed by crystallization of β-ACF by addition of a suitable solvent;
c) Optional repetition of step a) and b) in a sequential (clockwise) cyclic process.
3. The process according to claim 2, wherein the distillation to about 60 to 80 weight-% of step a) is carried out at 1 to 3 mbar and 200 to 210 0C heating temperature in a continuous thin- film evaporator.
4. The process according to claim 2 or 3, wherein step b) comprises the de- acetylation of α/β-ACF in the presence of a suitable base, followed by neutralization with a suitable acid and further followed by the re-acetylation reaction in the presence of suitable base, a suitable catalyst and a suitable acetylating agent.
5. The process according to any one of claims 1 to 4 for use during the manufacture of capecitabine.
6. The novel processes and uses substantially as described herein.
***
EP10700424.4A 2009-01-27 2010-01-18 Process for the recovery of beta-acetylfuranoside Active EP2391633B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP10700424.4A EP2391633B1 (en) 2009-01-27 2010-01-18 Process for the recovery of beta-acetylfuranoside
PL10700424T PL2391633T3 (en) 2009-01-27 2010-01-18 Process for the recovery of beta-acetylfuranoside
SI201030937T SI2391633T1 (en) 2009-01-27 2010-01-18 Process for the recovery of beta-acetylfuranoside

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09151384A EP2210895A1 (en) 2009-01-27 2009-01-27 Process for the recovery of beta-Acetylfuranoside
EP10700424.4A EP2391633B1 (en) 2009-01-27 2010-01-18 Process for the recovery of beta-acetylfuranoside
PCT/EP2010/050523 WO2010086247A1 (en) 2009-01-27 2010-01-18 Process for the recovery of beta-acetylfuranoside

Publications (2)

Publication Number Publication Date
EP2391633A1 true EP2391633A1 (en) 2011-12-07
EP2391633B1 EP2391633B1 (en) 2015-03-18

Family

ID=40801987

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09151384A Withdrawn EP2210895A1 (en) 2009-01-27 2009-01-27 Process for the recovery of beta-Acetylfuranoside
EP10700424.4A Active EP2391633B1 (en) 2009-01-27 2010-01-18 Process for the recovery of beta-acetylfuranoside

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP09151384A Withdrawn EP2210895A1 (en) 2009-01-27 2009-01-27 Process for the recovery of beta-Acetylfuranoside

Country Status (11)

Country Link
US (2) US20100190976A1 (en)
EP (2) EP2210895A1 (en)
JP (1) JP5612603B2 (en)
CN (2) CN102245621A (en)
CA (1) CA2748954C (en)
DK (1) DK2391633T3 (en)
ES (1) ES2535051T3 (en)
PL (1) PL2391633T3 (en)
SG (1) SG173113A1 (en)
SI (1) SI2391633T1 (en)
WO (1) WO2010086247A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2210895A1 (en) * 2009-01-27 2010-07-28 F. Hoffmann-La Roche AG Process for the recovery of beta-Acetylfuranoside
CN104017033B (en) * 2014-06-14 2016-08-17 济南尚博生物科技有限公司 A kind of method preparing glucosides
CN112125938A (en) * 2020-09-26 2020-12-25 安徽金禾实业股份有限公司 Method for extracting sucralose-6-ethyl ester from sugar residues

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1135258A (en) 1979-06-15 1982-11-09 Richard D'souza Process for the preparation of 5'deoxy-5-fluorouridine
DE3714473A1 (en) * 1987-04-30 1988-11-10 Basf Ag CONTINUOUS PROCESS FOR EPIMERIZING SUGAR, ESPECIALLY FROM D-ARABINOSE TO D-RIBOSE
ITMI20032059A1 (en) 2003-10-22 2005-04-23 Clariant Lsm Italia Spa PROCESS FOR THE PREPARATION OF DOXIFLURIDINE.
CN100383128C (en) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 Ramification of N-carbethoxy cytosine and preparation method and application
WO2008080822A1 (en) * 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Epimerization methodologies for recovering stereo isomers in high yield and purity
KR100908363B1 (en) * 2007-02-28 2009-07-20 한미약품 주식회사 Stereoselective preparation method of tri-O-acetyl-5-deoxy-β-D-ribofuranose and separation method thereof
EP2210895A1 (en) * 2009-01-27 2010-07-28 F. Hoffmann-La Roche AG Process for the recovery of beta-Acetylfuranoside

Also Published As

Publication number Publication date
DK2391633T3 (en) 2015-05-11
PL2391633T3 (en) 2015-08-31
CA2748954C (en) 2017-01-03
ES2535051T3 (en) 2015-05-04
SI2391633T1 (en) 2015-06-30
CN102245621A (en) 2011-11-16
EP2391633B1 (en) 2015-03-18
US9580455B2 (en) 2017-02-28
US20100190976A1 (en) 2010-07-29
WO2010086247A1 (en) 2010-08-05
CA2748954A1 (en) 2010-08-05
SG173113A1 (en) 2011-08-29
JP2012513970A (en) 2012-06-21
US20160333040A9 (en) 2016-11-17
CN106397503A (en) 2017-02-15
EP2210895A1 (en) 2010-07-28
US20130072674A1 (en) 2013-03-21
JP5612603B2 (en) 2014-10-22

Similar Documents

Publication Publication Date Title
US5298611A (en) Sucralose pentaester production
EP2828275B1 (en) Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
KR100390629B1 (en) Method for preparing sucralose without intermediate separation of crystalline sucralose-6-ester
KR20110101207A (en) Process for the synthesis of l-fucosyl dl- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof
Ying et al. General methods for the synthesis of glycopyranosyluronic acid azides
EP2391633B1 (en) Process for the recovery of beta-acetylfuranoside
JP2009542625A (en) Improved production of high purity sucralose
KR20140017624A (en) Process for preparation of ketolide compounds
EP2852583A1 (en) Sulfilimine and sulphoxide methods for producing festinavir
KR100908363B1 (en) Stereoselective preparation method of tri-O-acetyl-5-deoxy-β-D-ribofuranose and separation method thereof
CN110698468B (en) Preparation method of canagliflozin
CN106883227B (en) The method for preparing ergometrine by ergot fermentation waste
CN112358514B (en) Synthesis process of arbutin
Zong et al. Highly efficient removal of allyloxycarbonyl (Alloc) function provides a practical orthogonal protective strategy for carbohydrates
NO300638B1 (en) New and improved solvent-free synthesis of ether-substituted, blocked monosaccharides and their selective hydrolysis
CA2205535C (en) Sucralose pentaester production
EP2374809A1 (en) A process for the preparation of 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose
CN115322239A (en) Method for recovering diketone from double-alkyne carbon-lost ester mother liquor
CN107090009A (en) A kind of disaccharides nucleoside compound and preparation method thereof
TW491850B (en) Process for preparing etoposide
WO2009087677A1 (en) An improved process for the preparation of 1, 6-dichloro-1, 6-dide0xy-beta-d-fruct0furan0syl-4-chl0r0-4-de0xy-alpha-galact0py ranoside

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110829

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130308

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602010023169

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: C07H0003020000

Ipc: C07H0013040000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 13/04 20060101AFI20141020BHEP

INTG Intention to grant announced

Effective date: 20141120

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 716502

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150415

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010023169

Country of ref document: DE

Effective date: 20150430

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2535051

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20150504

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20150507

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150618

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150619

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

REG Reference to a national code

Ref country code: PL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150720

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150718

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010023169

Country of ref document: DE

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E024790

Country of ref document: HU

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: AT

Ref legal event code: UEP

Ref document number: 716502

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150318

26N No opposition filed

Effective date: 20151221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150318

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20221220

Year of fee payment: 14

Ref country code: IE

Payment date: 20221227

Year of fee payment: 14

Ref country code: GB

Payment date: 20221214

Year of fee payment: 14

Ref country code: FR

Payment date: 20221216

Year of fee payment: 14

Ref country code: CZ

Payment date: 20221227

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20221220

Year of fee payment: 14

Ref country code: BE

Payment date: 20221220

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20230208

Year of fee payment: 14

Ref country code: DK

Payment date: 20230103

Year of fee payment: 14

Ref country code: CH

Payment date: 20230201

Year of fee payment: 14

Ref country code: AT

Payment date: 20221227

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230117

Year of fee payment: 14

Ref country code: SI

Payment date: 20221227

Year of fee payment: 14

Ref country code: SE

Payment date: 20230110

Year of fee payment: 14

Ref country code: IT

Payment date: 20230116

Year of fee payment: 14

Ref country code: HU

Payment date: 20221219

Year of fee payment: 14

Ref country code: DE

Payment date: 20221215

Year of fee payment: 14

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230331

P02 Opt-out of the competence of the unified patent court (upc) corrected

Effective date: 20230410